Andrade-Villanueva, Jaime Federico
4 papers on CoChatORCID 0000-0003-1948-655X
Most cited papers
- Verified
Long-acting cabotegravir and rilpivirine dosed every 2 months in adults with HIV-1 infection (ATLAS-2M), 96-week results: a randomised, multicentre, open-label, phase 3b, non-inferiority study
Jaeger, H., Overton, E. T., Richmond, G., Rizzardini, G., Andrade-Villanueva, J. F., Mngqibisa, R., Hermida, A. O., Thalme, A., Belonosova, E., Ajana, F., et al. (2021) · The Lancet HIV
HIV/AIDS drug development and treatmentHIV/AIDS Research and Interventions
Cited by 142
- Verified
Oral manifestations associated with HIV/AIDS patients
Lomelí-Martínez, S. M., González-Hernández, L. A., Ruiz-Anaya, A. D. J., Lomelí-Martínez, M. A., Martínez-Salazar, S. Y., Mercado González, A. E., Andrade-Villanueva, J. F., & Varela-Hernández, J. J. (2022) · Medicina
HIV/AIDS oral health manifestationsOral Health Pathology and Treatment
Cited by 107
- Verified
Dolutegravir plus boosted darunavir versus recommended standard-of-care antiretroviral regimens in people with HIV-1 for whom recommended first-line non-nucleoside reverse transcriptase inhibitor therapy has failed (D2EFT): an open-label, randomised, phase 3b/4 trial
Matthews, G., Jacoby, S., Borok, M., Eriobu, N., Kaplan, R., Kumarasamy, N., Bennet, J. A., Avihingsanon, A., Chetchotisakd, P., Wagner Cardoso, S., et al. (2024) · The Lancet HIV
HIV/AIDS drug development and treatmentHIV/AIDS Research and Interventions
Cited by 31
- Verified
Differences in salivary flow level, xerostomia, and flavor alteration in Mexican HIV patients who did or did not receive antiretroviral therapy
López-Verdín, S., Andrade-Villanueva, J., Zamora-Perez, A. L., Bologna-Molina, R., Cervantes-Cabrera, J. J., & Molina-Frechero, N. (2013) · AIDS Research and Treatment
HIV/AIDS oral health manifestationsSalivary Gland Disorders and Functions
Cited by 21
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free